Sinovac Biotech Ltd (NASDAQ:SVA)
| 0.00 BATS BZX Real-Time Price As of Dec 30 |  0.00 / 0.00%Today’s Change | -- |||52-Week Range -- | -- Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Revenue and Income | Net Revenues | 67.4M | 72.4M | 174.3M | 229.7M | |
| Cost of Goods Sold | 12.2M | 17.3M | 15.6M | 19.8M | ||
| Depreciation And Amortization | 6.2M | 5.1M | 4.6M | 4.9M | ||
| Operating Expenses | Gross Income | 49.0M | 50.0M | 154.1M | 204.9M | |
| General Expenses | 46.9M | 56.0M | 108.8M | 160.3M | ||
| Research And Development | 9.5M | 12.6M | 20.5M | 21.9M | ||
| Total Operating Expenses | 65.3M | 78.4M | 129.0M | 185.0M | ||
| Non-Operating Expenses | Operating Income | 2.1M | -6.0M | 45.3M | 44.6M | |
| Interest Expense On Debt | 1.9M | 1.7M | 1.6M | 1.1M | ||
| Other Expenses | 1.7M | 6.6M | 112.0K | 1.0M | ||
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | 3.0M | -394.0K | 45.0M | 46.6M | |
| Income Taxes | -2.5M | -2.7M | -8.3M | -10.5M | ||
| Minority Interest | -861.0K | -124.0K | -10.9M | -14.3M | ||
| Discontinued Operations | -728.0K | -123.0K | 0.00 | 0.00 | ||
| Extraordinary Items | 0.00 | 2.5M | 0.00 | 0.00 | ||
| Net Income | -1.1M | -3.1M | 25.8M | 21.8M | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 56.3M | 56.9M | 57.0M | 64.7M | |
| Shares To Calculate EPS Diluted | 56.3M | 56.9M | 57.1M | 65.0M | ||
| Earnings Per Share | EPS | -$0.02 | -$0.01 | $0.45 | $0.34 | |
| EPS Diluted | -$0.02 | -$0.05 | $0.45 | $0.34 | ||
